Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 11 of 23
Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines
NCT05967442
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
NCT03870529
Virtual Behavioral Health Integration
NCT04106388
Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin
NCT03935399
Reducing the Experience of Menopausal Symptoms Through Temperature
NCT03937466
In Office Versus Telemedicine Preoperative Visit
NCT04023175
The Effect of Brimonidine
NCT03959176
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
NCT03963739
Connect Oncology Needs Evaluation Tool
NCT03919864
Implementation of Nurse-guided Web-based Cognitive Behavioral Therapy for Pain Management
NCT03927846
Palliative Radiation Oncology Chief's Clinic
NCT03995927
Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT
NCT03861091
No Drop Post-Op Cataract Surgery
NCT03864133
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
NCT03867175
Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety
NCT05110014
The Effects of MAP and EtCO2 on Venous Sinus Pressures
NCT03867461
A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease
NCT03740048
Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy
NCT03988270
Real-time Location System Feasibility Study
NCT03988751
Volunteering as an Intervention to Reduce Depression Among Adolescents
NCT03816215
The Effects of Sedatives on Tobacco Use Disorder
NCT03813121
Social Determinants of Health in Glioblastoma Population
NCT03900689
Medical Data Collection in the Formation of Precision Oncology Registry
NCT03874065
The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women
NCT03681691
PK Sampling After IV Oxytocin and Effects on Sensory Function in Healthy Volunteers
NCT03929367
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
NCT03696797
Carolinas Cardiogenic Shock Initiative
NCT04985708
Study of Nasal Insulin to Fight Forgetfulness - Device Study
NCT03857321
Effect of Opioid Shortage on Drug Selection
NCT04099030
Airway Deadspace in Children: Air-Q Versus Endotracheal Tube
NCT03785977
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
NCT03475186
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
NCT03796273
Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels
NCT03747523
Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty
NCT03409900
Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions
NCT03861065
Assessing Patient Anxiety During Mohs Micrographic Surgery
NCT03756792
Epigenetic and Metabolomic Changes in Childhood Cancer Survivors
NCT03866707
The Impact of Cytochrome P450 Abnormalities in Patients With Delirium.
NCT03829670
Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
NCT03529565
Improving Morbidity During Post-Acute Care Transitions for Sepsis
NCT03865602
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy
NCT03496805
The Endocannabinoid System in Human Gestational Tissues in Labor
NCT03752021
Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis
NCT03759847
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
NCT03152786
Liposomal Bupivacaine (Exparel) in Sarcomas
NCT03867188
LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)
NCT03593395
Comparison of Fluid Capture Efficiency of the Total Capture Drape Versus a Standard Drape for Hysteroscopy
NCT04540952
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
NCT03688126
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
NCT03773107
Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03188432
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.